Owlet (OWLTW) Non-Current Deffered Revenue (2020 - 2021)
Owlet (OWLTW) reported Non-Current Deffered Revenue of $258000.0 for Q3 2021, down 96.8% year-over-year from $8.0 million in Q3 2020, and down 96.8% on a QoQ basis from $8.0 million in Q2 2021.
Owlet (OWLTW) has 2 years of Non-Current Deffered Revenue data on file, last reported at $258000.0 in Q3 2021.
- Quarterly Non-Current Deffered Revenue fell 96.8% year-over-year to $258000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $258000.0 (down 96.8% YoY) and the FY2020 annual result came in at $159000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue declined to $258000.0 in Q3 2021 per OWLTW's latest filing, from $8.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $8.0 million in Q3 2020 and bottomed at $159000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Owlet | - | - | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 258,000.00 |
| Jun 30, 2021 | 8.05 Mn |
| Mar 31, 2021 | 8.05 Mn |
| Dec 31, 2020 | 159,000.00 |
| Sep 30, 2020 | 8.05 Mn |